Day 2 was the tale of the four I’s innovation, invention, industry and impact.
All words we are aware of in the UK but the people I met at Northeastern University and MIT today are doing things a little bit differently.
From a bioengineering perspective I have already realised that it is a very heterogeneous landscape here in the USA. MIT have their very specific approach BU theres and Northeastern a different approach again.
Northeastern’s Department of Bioengineering was officially founded in January 2014, that’s not a typo that really was last month. Previously there has been, as in other institutions a lot of biomedical engineering research undertaken in different engineering Departments.
Monday February 24th marked the first day of my two week tour of US bioengineering institutions and a fascinating start it has been.
I began my day at MIT where Professor Doug Lauffenburger had arranged a comprehensive schedule of meetings for me to gain an insight about bioengineering at MIT.
At MIT they approach bioengineering from the biological angle, as Professor Lauffenburger described to me in the morning each engineering discipline has a scientific knowledge base with a range of applications. However bioengineering has traditionally approached it differently with a broad foundation in a range of disciplines including maths, physics, chemistry and biology but with one primary application area of healthcare/ medicine.